Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
DRS. ABRAMS, médecine générale, algemene geneeskunde from Wemmel, company number BE0670589011, closed financial year 2025 with a result of € 69,588 after tax. For that financial year DRS. ABRAMS, médecine générale, algemene geneeskunde recorded revenue of € 252,318 and equity of € 364,295. Compared with financial year 2024, the result moved from € 63,492 to € 69,588. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 25, 2026.
€ 364,295
▲ 2% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 69,588
▲ 10% vs 2024
Profit after tax over the fiscal year.
€ 329,661
▲ 11% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 61,799 paid out
89 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 37,903
▲ € 37,804 vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 4,078
▲ 35% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 6,317
▲ 15% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 231,553 | € 243,208 | € 249,247 | € 252,318 | ▲ 1% |
| Gross margin | € 105,222 | € 109,188 | € 111,595 | € 122,453 | ▲ 10% |
| Profit after taxes | € 59,770 | € 63,826 | € 63,492 | € 69,588 | ▲ 10% |
| Equity | € 304,436 | € 344,962 | € 356,506 | € 364,295 | ▲ 2% |
| Total debts | € 57,908 | € 43,355 | € 64,718 | € 74,306 | ▲ 15% |
| Cash | € 274,376 | € 243,696 | € 295,718 | € 329,661 | ▲ 11% |
| Retained profit | € 298,236 | € 338,762 | € 350,306 | € 358,095 | ▲ 2% |
| Dividend | € 0 | € 23,300 | € 51,948 | € 61,799 | ▲ 19% |
| Balance sheet total | € 362,344 | € 388,317 | € 421,224 | € 438,601 | ▲ 4% |
Key figures of DRS. ABRAMS, médecine générale, algemene geneeskunde, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to DRS. ABRAMS, médecine générale, algemene geneeskunde?
What happened at DRS. ABRAMS, médecine générale, algemene geneeskunde in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 69,588 (▲ 10% vs 2024). Source: NBB ↗
- New establishment in Jette. KBO
- Start of the company according to the CBE. KBO
In short
From € 59,770 profit in 2022 to € 69,588 profit in 2025.
Paid € 99,172 in corporate taxes since 2022.
Best year ever: 2025, with € 69,588 profit.
Paid out € 137,047 in dividends to the owners in total.
Management
Behind DRS. ABRAMS, médecine générale, algemene geneeskunde are Guy ABRAMS and Pierre ABRAMS.
Directors
According to the 2025 annual accounts
Guy ABRAMS
Director
Pierre ABRAMS
Director
Establishments
Establishment units
Physical locations of this company
Obberg 77
1780 Wemmel
Dikke-Beuklaan 28
1090 Jette
Active since 31 January 2017
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0670.589.011
- VAT number
- BE 0670.589.011
- Registered office
- Obberg 77, 1780 Wemmel
- Names & denominations
- DRS. ABRAMS, médecine générale, algemene geneeskunde
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 31 January 2017
- Peppol
- Not registered